"These products are not offered in countries where valid patents exist. However,final responsibility with respect to third party's patent rights in a specific country lies exclusively with the user."

ACTIVE PHARMACEUTICAL INGREDIENTS
  • Ciprofloxacin Hydrochloride UPS
    (U.S.DMF No. 17786)
  • Diclofenac Acid
    (U.S.DMF No. 15366)

  • Diclofenac Diethylamine BP
    (Spain DMF No. DD-708 / 01)

  • Diclofenac Potassium BP/EP
    (Plant approved by FDA, U.S.A. - U.S.DMF No. 15074)

  • Diclofenac Sodium BP/EP/USP
    (U.S. DMF No 12469)
    (Certicate of Suitability No. R1-CEP-1997-041-REV 00) dtd. 18th March, 2003.

  • Diclofenac Sodium BP/EP/USP also Injectable Grade

  • Metronidazale BP/EP/USP
    (Plant approved by FDA, U.S.A. - U.S.DMF No. 3675)
    (Plant approved by T.G.A. Australia)
    (Certicate of Suitability No. R1-CEP 1997-083- REV 00) dtd. 20th July, 2003.
    (Canadian DMF No.2001 - 054)

  • Metronidazole BP/EP/USP also Injectable Grade

  • Metronidazole Benzoate BP/EP/USP
    (Benzoyl Metronidazole)

  • Nifedipine BP/EP/USP
    (US DMF No. 16730)
    (Certificate of Suitability No. RO-CEP 2000-096- REV. 01) dtd. 29th June, 2003.


 



INTERMEDIATES

  • 2-Methylimidazole

  • N- Chloroacetyl N- Phenyl2,6 Dichloro Aniline (CPDCA)

  • 1- (2,6- Dichlorophenyl)- 2- Indolinone (INDOLINONE)



Brands | API | Formulations



 
Copyright © 2005 J. B. Chemicals & Pharmaceuticals Ltd. All rights reserved.